Skip to content
Laboratory research supply
Research information

Semax research profile

What is being studied?

Semax is a synthetic heptapeptide comprising the ACTH(4-7) sequence followed by Pro-Gly-Pro. It is studied as a short regulatory-peptide reference without the full adrenocorticotropic hormone sequence.

Preclinical studies have examined neurotrophin and receptor-gene transcription in rat brain models, while biochemical work has characterised Semax-copper complexes and cell-line responses. These findings are model-specific and do not establish a defined outcome in humans or animals.

Research areas

  • ACTH-fragment and Pro-Gly-Pro structure-activity comparisons
  • Neurotrophin and receptor-gene transcription studies
  • Peptide-metal binding and cell-response assays

Selected studies

How to read this research

These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.

Technical product record

Semax research record

Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.

Molecular identity

Synthetic ACTH(4-7)-Pro-Gly-Pro heptapeptide

Sequence / composition

Met-Glu-His-Phe-Pro-Gly-Pro

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.

1 / 1
WhatsApp us